arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

McKesson Corporation

MCK Health Care Other Pharmaceuticals
$907.99
▲ +0.0% Today
as of Sep 4, 16:51 ET
Last 30 days +2.08% Jul 28 → Sep 04
$819.33 $847.64 $875.96 $904.28 $932.59 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$911.15
High
$921.09
Low
$905.10
Volume
$683,155
Avg Vol
$874,357
Mkt Cap
$99.9B
P/E (TTM)
37.76
Beta
—
52w High
$999.00
52w Low
$682.35
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 3 ● 21 ▼ 1
Sep 4 · 15:30 Zacks neutral
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report?
Sep 4 · 12:43 Barchart neutral
McKesson Stock: Is MCK Outperforming the Healthcare Sector?
Sep 3 · 11:36 MT Newswires neutral
Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$682
$999
71% of range
Avg surprise (last 3)
+1.5%
Avg reaction (last 2)
-1.5%
50% positive
Latest IV / EM
23%
EM ±3.7% · $910 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.87$4.33$6.78$9.23$11.69 Actual $7.02Actual $4.92Actual $4.42Actual $7.00Actual $1.87Actual $6.95Actual $10.12Est $9.81Actual $8.26Est $8.23Actual $8.92Actual $9.59Actual $11.69Est $11.56Actual $5.15 JunSepDecJunSepDecMar/2025Jun/2025SepDecMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$27.9B$55.7B$83.6B$111.5B Sep 24Dec 24Jun 25Sep 25Dec 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $5.15 — — — — financials
Thu May 7, 2026Mar/2026 $11.69 $11.56 +1.1% +15.5% +1.5% earnings
Wed Dec 31, 2025Dec 2025 $9.59 — — — — financials
Tue Sep 30, 2025Sep 2025 $8.92 — — — — financials
Wed Aug 6, 2025Jun/2025 $8.26 $8.23 +0.4% — — earnings
Thu May 8, 2025Mar/2025 $10.12 $9.81 +3.2% — -4.4% earnings
Tue Dec 31, 2024Dec 2024 $6.95 — — — — financials
Mon Sep 30, 2024Sep 2024 $1.87 — — — — financials
Sun Jun 30, 2024Jun 2024 $7.00 — — — — financials
Sun Dec 31, 2023Dec 2023 $4.42 — — — — financials
Sat Sep 30, 2023Sep 2023 $4.92 — — — — financials
Fri Jun 30, 2023Jun 2023 $7.02 — — — — financials
Sat Dec 31, 2022Dec 2022 $7.66 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$105.38B—$106.16B$103.15B$97.83B—$95.29B$93.65B
Cost of revenue$101.69B—$102.47B$99.61B$94.55B—$92.01B$90.40B
Gross profit$3.69B—$3.69B$3.54B$3.28B—$3.28B$3.25B
Operating income$1.32B—$1.62B$1.41B$1.04B—$1.22B$578M
Net income$614M—$1.19B$1.11B$784M—$879M$241M
EPS (diluted)$5.15—$9.59$8.92$6.25—$6.95$1.87

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$5.16B$3.98B$2.96B$4.00B$2.42B$5.69B$1.13B$2.51B
Inventory$26.26B$24.21B$27.07B$26.13B$25.07B$23.00B$23.84B$24.18B
Total current assets$62.84B$57.21B$59.70B$59.89B$56.80B$55.40B$51.74B$53.34B
Total assets$88.33B$82.32B$84.19B$84.16B$81.31B$75.14B$71.08B$72.43B
Long-term debt$9.73B$6.53B$6.56B$7.76B$7.78B—$5.59B$5.74B
Total liabilities————————
Total equity$-4.24B$-2.17B$-1.30B$-1.35B$-1.59B$-2.07B$-2.70B$-2.64B

Implied volatility — last 90 days

23%28%34%39%45% Jun 07 — IV 30% · EM ±4.2%Jun 08 — IV 31% · EM ±4.0%Jun 09 — IV 31% · EM ±3.9%Jun 10 — IV 29% · EM ±3.4%Jun 11 — IV 30% · EM ±3.3%Jun 12 — IV 29% · EM ±3.0%Jun 15 — IV 32% · EM ±2.3%Jun 16 — IV 33% · EM ±1.9%Jun 17 — IV 36% · EM ±1.5%Jun 19 — IV 28% · EM ±6.2%Jun 22 — IV 29% · EM ±6.0%Jun 23 — IV 28% · EM ±5.8%Jun 24 — IV 27% · EM ±5.4%Jun 25 — IV 26% · EM ±5.2%Jun 26 — IV 26% · EM ±4.9%Jun 29 — IV 27% · EM ±4.8%Jun 30 — IV 27% · EM ±4.7%Jul 01 — IV 27% · EM ±4.4%Jul 02 — IV 25% · EM ±4.0%Jul 03 — IV 26% · EM ±4.0%Jul 06 — IV 29% · EM ±4.0%Jul 07 — IV 25% · EM ±3.3%Jul 08 — IV 29% · EM ±3.7%Jul 09 — IV 28% · EM ±3.3%Jul 10 — IV 26% · EM ±2.8%Jul 13 — IV 33% · EM ±2.8%Jul 14 — IV 31% · EM ±2.3%Jul 15 — IV 33% · EM ±1.9%Jul 16 — IV 36% · EM ±1.5%Jul 20 — IV 35% · EM ±8.4%Jul 21 — IV 36% · EM ±8.3%Jul 22 — IV 35% · EM ±8.1%Jul 23 — IV 36% · EM ±8.1%Jul 24 — IV 35% · EM ±7.8%Jul 27 — IV 37% · EM ±7.7%Jul 28 — IV 35% · EM ±7.2%Jul 29 — IV 36% · EM ±7.2%Jul 30 — IV 37% · EM ±7.3%Jul 31 — IV 37% · EM ±7.1%Aug 03 — IV 41% · EM ±7.3%Aug 04 — IV 43% · EM ±7.3%Aug 05 — IV 45% · EM ±7.6%Aug 06 — IV 29% · EM ±4.8%Aug 07 — IV 29% · EM ±4.5%Aug 10 — IV 28% · EM ±3.9%Aug 11 — IV 25% · EM ±3.3%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 33% · EM ±3.9%Aug 14 — IV 28% · EM ±3.1%Aug 17 — IV 35% · EM ±3.0%Aug 18 — IV 33% · EM ±2.4%Aug 19 — IV 33% · EM ±2.0%Aug 20 — IV 37% · EM ±1.5%Aug 24 — IV 26% · EM ±5.5%Aug 25 — IV 25% · EM ±5.1%Aug 26 — IV 25% · EM ±4.9%Aug 27 — IV 24% · EM ±4.8%Aug 28 — IV 24% · EM ±4.7%Aug 31 — IV 24% · EM ±4.3%Sep 01 — IV 24% · EM ±4.1%Sep 02 — IV 24% · EM ±4.0%Sep 03 — IV 23% · EM ±3.8%Sep 04 — IV 23% · EM ±3.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in